News
![access-to-the-vaccine](https://pharmaphorum.com/wp-content/uploads/2022/05/access-to-the-vaccine.jpg)
GSK bolsters vaccines division with $3.3bn swoop on Affiniva...
GlaxoSmithKline has agreed a $3.3 billion takeover of US biotech Affinivax, buying a pneumococcal vaccine candidate that is aiming to break into a market that for years has been dominated b